CLINICAL// TRANSLATIONAL

INCREASED ACTIVITY MAY
PREVENT COGNITIVE DECLINE

Participating in cognition-enhancing
activities might reduce African
Americans' risk for dementia.

AFRICAN AMERICANS ARE AT NEARLY TWICE THE RISK AS
Caucasians for developing Alzheimer’s and other
dementias. Yet, no interventions have been shown
to reduce this disparity.
Barry Rovner, MD, professor of psychiatry,
neurology and ophthalmology, and a clinical
expert in Alzheimer’s disease, has been intensely
studying racial-based disparities in the incidence
and outcomes of dementia. In one notable study,
he and Robin Casten, PhD, professor of psychiatry,
found that African Americans were less likely than
whites to recognize cognitive decline as a medical

26

THOMAS JE FFE RSON UNIVE RSIT Y // Jef ferson.edu/Research2020

problem. Those findings suggested that culturally
specific interventions might help reduce African
Americans’ risk for developing dementia.
Therefore, Drs. Rovner and Casten undertook an
NIH-funded trial of a behavioral intervention that
increased participation in cognitive, physical and
social activities among African Americans with mild
cognitive impairment, a transition state between
expected cognitive aging and dementia. In the
intervention, community health workers used
goal setting and action planning to guide at-risk
participants in concrete steps to increase cognition-

enhancing activities. In results published last year,
the research team reported that the intervention had
clear benefit in helping prevent memory decline in
this high-risk population. The behavioral intervention
reduced risk of cognitive decline by 88 percent,
compared to a control group.
Dr. Rovner attributes much of the intervention’s
success to the study’s sensitivity to the perceptions
of the African American participants. The
community health workers were themselves
African American, and the participants were able
to self-select the specific activities they pursued—
which included relearning chess, playing guitar,
rejoining a church group, making plans to meet
friends for lunch and walking to appointments.

microvascular disease and neurodegeneration and,
thereby, increase risk for dementia. The number of
older African Americans with diabetes in the U.S. will
double by 2030, and African Americans have worse
glycemic control than Caucasians.
To address these disparities—and the related
incidence of dementia—Drs. Rovner and Casten are
planning a clinical trial on the Efficacy of DiabetesSpecific Behavioral Activation. The researchers
hope that, by reinforcing diabetes self-care and
addressing African Americans’ negative beliefs about
medications and physicians, the intervention will
simultaneously improve diabetes care and prevent
dementia in this high-risk population. 

While conducting the study, the researchers
became more aware of the problems facing
African Americans with diabetes—which can cause
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